Skip to main content

Table 4 Representative scores (most frequently observed) of the immunolabeling, categorized as mild/discrete (+), moderate (++), or intense (+++), according to the area/quantity of positive cells for each antigen in all groups in both periods

From: Gene expression, immunohistochemical and microarchitectural evaluation of bone formation around two implant surfaces placed in bone defects filled or not with bone substitute material

 

RUNX2

OPN

OCN

OPG

RANKL

15 days

 BC-N

+++

++

+++

++

+++

 HA/TCP-N

+++

+++

+++

+++

+++

 BC-A

+++

++

++

++

++

 HA/TCP-A

++

++

++

++

++

30 days

 BC-N

+

++

++

++

++

 HA/TCP-N

++

+

++

++

++

 BC-A

+++

++

++

++

++

 HA/TCP-A

++

++

++

++

++